Injections produce larger average weight losses in trials, but tablets work for many people, especially if you stick with them
Gibson R, Krug L, Ramsey DL, Safaei A, Aspley S
The post points to people with prior sensitivity to GLP-1 side effects, significant insulin resistance needing metabolic stabilization, a history of nausea or gastrointestinal conditions, and comorbidities that call for conservative pharmacotherapy
Mounjaro and Zepbound both contain tirzepatide, a dual GIP and GLP-1 receptor agonist
Lets now look at semaglutide The study The semaglutide for obesity study was published in the New England Journal of Medicine on February 10th, 2021 (Ref 4)
You should avoid jumping into overly intense workouts, especially when you first start